Invesco
ENZN

Invesco’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Invesco’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-314,907
Closed -$343K – 4123
2014
Q4 		$343K Buy
314,907
+16,095
+5% +$16.9K ﹤0.01% 3461
2014
Q3 		$323K Buy
298,812
+14,982
+5% +$18.5K ﹤0.01% 3479
2014
Q2 		$295K Buy
283,830
+2
+0% +$2 ﹤0.01% 3546
2014
Q1 		$292K Buy
283,828
+185,557
+189% +$192K ﹤0.01% 3598
2013
Q4 		$114K Sell
98,271
-129,320
-57% -$199K ﹤0.01% 3998
2013
Q3 		$382K Sell
227,591
-150,270
-40% -$278K ﹤0.01% 3512
2013
Q2 		$756K Buy
+377,861
New +$1.11M ﹤0.01% 3061

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Invesco's ENZN Position: Q1 2015 in Review

Invesco sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2015, closing a stake of 314,907 shares — an estimated $343K sold.

Invesco first reported a position in ENZN in Q2 2013 and held it in 7 quarters. The position peaked at $756K in Q2 2013. 53 funds tracked by Wall St. Rank hold ENZN as of Q1 2015.

  • Invesco reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Invesco sold 314,907 ENZON PHARMACEUTICALS INC shares in Q1 2015, an estimated $343K.
  • Invesco first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Invesco's ENZON PHARMACEUTICALS INC position peaked at $756K in Q2 2013.
  • 53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2015.

Based on Invesco's 13F filing for Q1 2015, filed 15 May 2015.